2030년까지 중동 및 아프리카 근육감소증 치료 시장 전망 - 지역 분석 - 치료 유형(비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등) 및 유통 채널(약국, 소매 채널, 온라인 채널 및 기타)별
사코페니아에 대한 인식 상승 중동 및 아프리카 근육감소증 치료 시장
사코페니아에 대한 인식 증가와 건강에 미치는 부정적인 영향 의료 및 노인 간호 분야의 발전을 위한 중요한 범위를 제시합니다. 많은 옹호 단체와 조직은 대중에게 근육감소증에 대한 인식을 높이기 위해 적극적으로 조치를 취하고 있습니다. 이러한 조직은 종종 의료 전문가와 협력하여 병원성, 대상 환자, 예방 및 치료와 같은 특정 질환의 다양한 측면에 대한 최신 정보를 대중에게 알리고 즉각적인 진단 및 치료의 가치를 강조합니다. OWH의 \"근육감소증보다 강함\" 캠페인에 따라 여성들은 근육감소증에 대해 의료 서비스 제공자와 논의한 후 질병에 대한 선별검사를 받고 필요한 경우 적절한 치료를 받을 것을 권장합니다.
근육감소증은 의과대학 커리큘럼과 의사, 간호사, 물리치료사 등 의료 전문가를 위한 훈련 프로그램에 포함되어 있습니다. 예를 들어, OWH는 Medscape Education과 협력하여 의료 전문가를 위한 지속적인 의학 교육(CME) 학점을 만들어 환자의 근육감소증을 발견하고 치료할 수 있는 능력을 더욱 향상시켰습니다. 주류 언론은 기사, 뉴스 기사, 다큐멘터리 등을 포함하여 근육감소증에 대한 보도를 확대했습니다. 따라서 근육감소증에 대한 인식이 높아지면서 향후 근육감소증 치료 시장에 새로운 성장 추세가 나타날 가능성이 높습니다.
중동 및 아프리카 근육감소증 치료 시장 개요
중동 및 아프리카 근육감소증 치료 시장은 사우디아라비아, UAE, 남아프리카 및 나머지 MEA 지역으로 분류됩니다. UAE와 사우디아라비아는 정형외과 질환 발병률 증가로 인해 시장에 가장 크게 기여한 국가 중 하나입니다. 영양 보충제의 사용과 이점에 대한 많은 인구의 인식이 높아지면 시장 발전에도 도움이 됩니다.
남아프리카공화국에서 근육감소증의 위험 증가는 인구 노령화, 빈곤으로 인한 부적절한 식량 안보 및 영양 섭취와 관련이 있습니다. 이 나라의 근육감소증 치료 시장은 근육감소증의 진단, 치료 및 예방을 위해 보건 당국이 취하는 독특한 인구 집단별 접근법에 의해 주도될 것으로 예상됩니다.
중동 및 아프리카 근육감소증 치료 시장 수익 및 예측(미화 백만 달러)
중동 및 아프리카 근육감소증 치료 시장 세분화
중동 및 아프리카 근육감소증 치료 시장은 치료 유형, 유통 채널, 국가로 분류됩니다.
중동 및 아프리카 근육감소증 치료 시장은 치료 유형에 따라 비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등으로 분류됩니다. 비타민 D 및 칼슘 보충제 부문은 2022년 중동 및 아프리카 근육감소증 치료 시장에서 가장 큰 점유율을 차지했습니다.
유통 채널 측면에서 중동 및 아프리카 근육감소증 치료 시장은 약국, 소매 채널, 온라인으로 분류됩니다. 채널 및 기타. 약국 부문은 2022년에 가장 큰 중동 및 아프리카 근육감소증 치료 시장 점유율을 차지했습니다.
국가별로 중동 및 아프리카 근육감소증 치료 시장은 사우디아라비아, 남아프리카, 아랍에미리트 및 나머지 국가로 분류됩니다. 중동 및 아프리카. 남아프리카공화국은 2022년 중동 및 아프리카 근육감소증 치료 시장 점유율을 장악했습니다.
Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp 및 GSK Plc는 그 중 일부입니다. 중동 및 아프리카 근육감소증 치료 시장의 주요 기업
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis
6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country
Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 17. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.